Literature DB >> 30573033

Future of Personalized Cardiovascular Medicine: JACC State-of-the-Art Review.

Robert M Califf1.   

Abstract

Previous decades have seen significant progress in the biological understanding of cardiovascular disease, as well as major advances in computational and information technologies. However, anticipated improvements in outcomes, quality, and cost of cardiovascular medicine at the individual and population levels from these advances have lagged expectations. Further, trends showing widening gaps in the pace of technological development and its successful uptake and application in practice suggests that substantial systemic changes are needed. Recent declines in key U.S. health outcomes have added further urgency to seek scalable approaches that deliver the right treatment to the right patient and to develop information-driven policies that improve health. The clinical care and research enterprises are currently in the midst of assimilating changes entrained by a "fourth industrial revolution" marked by the convergence of biology, physical sciences, and information science. These changes, if managed appropriately, can simultaneously enable cost-effective personalized medical care as well as more effective and targeted population health interventions. In this paper derived from a lecture in honor of cardiologist Paul Dudley White, the author explores how White's prescient insights into prevention and treatment continue to resonate today as we seek to assimilate ubiquitous computing, sophisticated sensor technologies, and bidirectional digital communication into the practice of cardiology. How the ongoing acceleration in basic science and information technologies can be wedded to the principles articulated by White as we pursue scalable approaches to personalized medicine is also examined.
Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  data science; electronic health record; precision medicine; registry

Mesh:

Substances:

Year:  2018        PMID: 30573033     DOI: 10.1016/j.jacc.2018.09.079

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  5 in total

1.  Real-World Evidence for Medication Safety: Causal, Confounded, or Capable?

Authors:  Emily C O'Brien; Stephen J Greene
Journal:  JACC Heart Fail       Date:  2019-09-11       Impact factor: 12.035

Review 2.  Systems biology in cardiovascular disease: a multiomics approach.

Authors:  Abhishek Joshi; Marieke Rienks; Konstantinos Theofilatos; Manuel Mayr
Journal:  Nat Rev Cardiol       Date:  2020-12-18       Impact factor: 32.419

3.  Mitral valve repair: moving towards a personalized ring.

Authors:  Antonios Pitsis; Timotheos Kelpis; Efstratios Theofilogiannakos; Nikolaos Tsotsolis; Harisios Boudoulas; Konstantinos Dean Boudoulas
Journal:  J Cardiothorac Surg       Date:  2019-06-13       Impact factor: 1.637

4.  Wearable health devices and personal area networks: can they improve outcomes in haemodialysis patients?

Authors:  Jeroen P Kooman; Fokko Pieter Wieringa; Maggie Han; Sheetal Chaudhuri; Frank M van der Sande; Len A Usvyat; Peter Kotanko
Journal:  Nephrol Dial Transplant       Date:  2020-03-01       Impact factor: 5.992

5.  Medical Practice in a Changing World: Reflections From the 19th Century.

Authors:  Eduardo Vilela; Ricardo Fontes-Carvalho
Journal:  JACC Case Rep       Date:  2022-07-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.